GL1X · GenesisL1 explorer

Research workbench

ALK5 in complex with 4-((5,6-dimethyl-2-(2-pyridyl)-3-PYRIDYL)OXY)-N- (3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-amine

Analyse ALK5 in complex with 4-((5,6-dimethyl-2-(2-pyridyl)-3-PYRIDYL)OXY)-N… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WOT
Type
protein
Length
303 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TGF-beta receptor type-1
EC
2.7.11.30
UniProt
P36897
Ligands
ZZG
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATGF-beta receptor type-1 (EC 2.7.11.30)protein30339% helix, 20% strandP36897

Ligands and binding sites

  • ZZG · 4-[(5,6-dimethyl-2,2'-bipyridin-3-yl)oxy]-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1840.770.9920empty
23180.700.8436ZZG
3530.430.8417empty
4660.330.7614empty

Compared structures

  • 2WOT · ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphen… · the same entry in another collection · chain A against A, TM-score 1.00
  • P36897 · AlphaFold monomer V2.0 prediction for TGF-beta receptor type-1 (P36897) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.